BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31139821)

  • 1. Strategies to Address Challenges in Neuroscience Drug Discovery and Development.
    O'Donnell P; Rosen L; Alexander R; Murthy V; Davies CH; Ratti E
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):445-448. PubMed ID: 31139821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders.
    Sarnyai Z; Guest PC
    Adv Exp Med Biol; 2017; 974():97-114. PubMed ID: 28353227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Tolerance: A Known Unknown in Translational Neuroscience.
    Bespalov A; Müller R; Relo AL; Hudzik T
    Trends Pharmacol Sci; 2016 May; 37(5):364-378. PubMed ID: 26935643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General overview: biomarkers in neuroscience research.
    Filiou MD; Turck CW
    Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Monitor Molecules in Neuroscience?
    Andrews AM
    ACS Chem Neurosci; 2017 Feb; 8(2):211-212. PubMed ID: 28196419
    [No Abstract]   [Full Text] [Related]  

  • 6. Revitalizing psychiatric drug discovery.
    Sarter M; Tricklebank M
    Nat Rev Drug Discov; 2012 Jun; 11(6):423-4. PubMed ID: 22653200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.
    Van der Schyf CJ
    Drug Dev Res; 2016 Dec; 77(8):458-468. PubMed ID: 27813127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Translational Neuroscience: Narrowing Distances for Future Discoveries.
    De Souza Crippa JA; Guimarães FS; Joca S
    CNS Neurol Disord Drug Targets; 2015; 14(8):962. PubMed ID: 26373939
    [No Abstract]   [Full Text] [Related]  

  • 11. New approaches in psychiatric drug development.
    van der Doef TF; Zaragoza Domingo S; Jacobs GE; Drevets WC; Marston HM; Nathan PJ; Tome MB; Tamminga CA; van Gerven JMA; Kas MJH
    Eur Neuropsychopharmacol; 2018 Sep; 28(9):983-993. PubMed ID: 30056086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three paths to drug discovery in psychiatry.
    Berk M; Nierenberg AA
    Am J Psychiatry; 2015 May; 172(5):412-4. PubMed ID: 25930130
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers in psychotropic drug development.
    Ahmed S; Mozley PD; Potter WZ
    Am J Geriatr Psychiatry; 2002; 10(6):678-86. PubMed ID: 12427576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational challenges of animal models in Chagas disease drug development: a review.
    Chatelain E; Konar N
    Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathophysiological paradigm for the therapy of psychiatric disease.
    Spedding M; Jay T; Costa e Silva J; Perret L
    Nat Rev Drug Discov; 2005 Jun; 4(6):467-76. PubMed ID: 15931256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease drug development: translational neuroscience strategies.
    Cummings JL; Banks SJ; Gary RK; Kinney JW; Lombardo JM; Walsh RR; Zhong K
    CNS Spectr; 2013 Jun; 18(3):128-38. PubMed ID: 23472637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders.
    Rahmoune H; Martins-de-Souza D; Guest PC
    Adv Exp Med Biol; 2017; 974():69-84. PubMed ID: 28353225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker identification in psychiatric disorders: from neuroscience to clinical practice.
    Razafsha M; Khaku A; Azari H; Alawieh A; Behforuzi H; Fadlallah B; Kobeissy FH; Wang KK; Gold MS
    J Psychiatr Pract; 2015 Jan; 21(1):37-48. PubMed ID: 25603450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valley of death: A proposal to build a "translational bridge" for the next generation.
    Gamo NJ; Birknow MR; Sullivan D; Kondo MA; Horiuchi Y; Sakurai T; Slusher BS; Sawa A
    Neurosci Res; 2017 Feb; 115():1-4. PubMed ID: 27876581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.